Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideIVZInvesco
FinDog View：Neutral
MSMorgan Stanley
FinDog View：Bearish
| Metric | IVZ | MS |
|---|
| Close | 30.08 | 202.42 |
| Market Cap | $13.3B | $318B |
| 1M | −7.65% | −7.24% |
| P/E (TTM) | — | 15.8 |
| Forward P/E | 9.7 | 15.7 |
| P/E 5-Yr Percentile | — | 0 |
| P/S | 2.5 | 2.5 |
| P/B | 1.1 | 2.7 |
| Dividend Yield | 5.79% | 4.32% |
| Latest Quarter Revenue | $1.8B | $21.3B |
| Revenue YoY | +20.5% | +27.1% |
| Gross Margin | — | — |
| Latest Quarter EPS | 0.76 | 3.46 |
| Avg Post-Earnings Move | ±1.4% | ±2.4% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 4.19% | 2.13% |
| 90-Day Net Insider Buying | −$7.2M | −$8.9M |
IVZ · Revenue, Last 8 Quarters ($B)
MS · Revenue, Last 8 Quarters ($B)
